Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria

Multidrug-resistant (MDR) bacteria pose a grave concern to global health, which is perpetuated by a lack of new treatments and countermeasure platforms to combat outbreaks or antibiotic resistance. To address this, we have developed a Facile Accelerated Specific Therapeutic (FAST) platform that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Eller, Kristen A., Aunins, Thomas R., Courtney, Colleen M., Campos, Jocelyn K., Otoupal, Peter B., Erickson, Keesha E., Madinger, Nancy E., Chatterjee, Anushree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955031/
https://www.ncbi.nlm.nih.gov/pubmed/33712689
http://dx.doi.org/10.1038/s42003-021-01856-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955031/
https://www.ncbi.nlm.nih.gov/pubmed/33712689
http://dx.doi.org/10.1038/s42003-021-01856-1

Ejemplares similares